Sol-Gel Technologies Ltd. (SLGL)
73.86
-1.42
(-1.89%)
USD |
NASDAQ |
May 29, 16:00
75.00
+1.14
(+1.54%)
After-Hours: 20:00
Sol-Gel Technologies EPS Diluted (Quarterly) : -1.314 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 0.3121 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.2293 |
| Purple Biotech Ltd. | -0.0997 |
| PolyPid Ltd. | -0.3525 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.727M |
| Revenue (Quarterly) | 0.108M |
| Total Expenses (Quarterly) | 3.835M |
| Enterprise Value | 153.79M |
| Profit Margin (Quarterly) | -3.45K% |
| Earnings Yield | -0.48% |
| Normalized Earnings Yield | -0.4756 |